These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31933967)
1. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature. Chen J; Feng J; Xiao H; Ma Q; Chen Z Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967 [TBL] [Abstract][Full Text] [Related]
2. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347 [TBL] [Abstract][Full Text] [Related]
3. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report. Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318 [No Abstract] [Full Text] [Related]
4. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review. Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359 [TBL] [Abstract][Full Text] [Related]
5. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature. Ghezavati A; Liang CA; Mais D; Nazarullah A J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402 [TBL] [Abstract][Full Text] [Related]
6. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome. Walters M; Pittelkow MR; Hasserjian RP; Harris NL; Macon WR; Kurtin PJ; Rech KLG Am J Surg Pathol; 2018 Dec; 42(12):1647-1652. PubMed ID: 30222603 [TBL] [Abstract][Full Text] [Related]
7. Indolent T-lymphoblastic proliferation: a report of three cases. Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472 [TBL] [Abstract][Full Text] [Related]
8. [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: A case report]. Chauveau B; Le Loarer F; Bacci J; Baylac F; Dubus P; Ling C; Parrens M Ann Pathol; 2019 Feb; 39(1):29-35. PubMed ID: 30554835 [TBL] [Abstract][Full Text] [Related]
9. Hepatic carcinoma with indolent T-lymphoblastic proliferation (iT-LBP). Kong M; Wang Z; Teng X; Xu L; Liu J; Jiang C; Teng L Int J Clin Exp Pathol; 2018; 11(3):1674-1678. PubMed ID: 31938268 [TBL] [Abstract][Full Text] [Related]
10. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease. Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658 [TBL] [Abstract][Full Text] [Related]
11. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma. Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427 [TBL] [Abstract][Full Text] [Related]
13. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease. Karki NR; Arfa AS; Savage N; Kutlar A Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661 [TBL] [Abstract][Full Text] [Related]
14. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769 [TBL] [Abstract][Full Text] [Related]
15. Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases. Saglam A; Singh K; Gollapudi S; Kumar J; Brar N; Butzmann A; Warnke R; Ohgami RS Int J Lab Hematol; 2022 Aug; 44(4):700-711. PubMed ID: 35577551 [TBL] [Abstract][Full Text] [Related]
16. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract. Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290 [TBL] [Abstract][Full Text] [Related]
17. Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease. Quesada AE; Young KH; Medeiros LJ; Thakral B Pathology; 2018 Apr; 50(3):351-352. PubMed ID: 29486963 [No Abstract] [Full Text] [Related]
18. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression. Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611 [TBL] [Abstract][Full Text] [Related]
19. Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty. Medina EA; Fuehrer NE; Miller FR; Kinney MC; Higgins RA Pathol Int; 2016 Sep; 66(9):535-9. PubMed ID: 27593552 [TBL] [Abstract][Full Text] [Related]
20. B-cell lymphoma with hyaline vascular Castleman disease-like features: a clinicopathologic study. Siddiqi IN; Brynes RK; Wang E Am J Clin Pathol; 2011 Jun; 135(6):901-14. PubMed ID: 21571963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]